(Q37760885)

22 August 2017

1 reference

title

Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge (English)

1 reference

inflammatory breast cancer

22 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Peter B Vermeulen

1

1 reference

22 August 2017

Kenneth L van Golen

series ordinal

2

1 reference

22 August 2017

Luc Y Dirix

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

116

1 reference

22 August 2017

issue

11 Suppl

1 reference

22 August 2017

page(s)

2748-2754

1 reference

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

The medical treatment of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Precancerous stem cells can serve as tumor vasculogenic progenitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Persistent E-cadherin expression in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

A stromal gene signature associated with inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25169

7 January 2021

Identifiers

DOI

10.1002/CNCR.25169

1 reference

22 August 2017

1 reference